ONCOVIX™
HIGH-END PERSONALIZED IMMUNOBIOLOGY
1 PROTOCOL · 1 PATIENT
A clinical, molecular, immunological, metabolic, and longitudinal architecture designed based on the real situation of each patient.
Every disease has a distinct trajectory. Every patient presents different medical history, treatments, responses, functional reserves, and integration needs. ONCOVIX™ starts from that individuality.
Through a structured clinical and molecular evaluation, the program identifies which biological dimensions remain active, which have been covered by previous treatments, and what complementary immunobiological architecture can be evaluated for the current clinical moment.
What is ONCOVIX™?
ONCOVIX™ is the personalized clinical-immunobiological expression of the PLPC™ Platform.
Its design is based on integrating, for each patient:
- 📋Diagnosis & trajectory
- 🔬Organic reserve
- 🖼️Pathology & imaging
- 📅Follow-up needs
- 💊Previous treatments
- 🔗Integration possibilities
- 📈Response or progression
- 🎯Clinical objectives
- 🧬Biomarkers & molecular
What does 1 Protocol · 1 Patient mean?
It means that each program is analyzed and structured individually. The evaluation determines what information is relevant, which mechanisms require deeper reading, what objectives can be set, and how the program should be coordinated.
Comprehensive
history review
history review
Clinical situation
characterization
characterization
Molecular &
immune reading
immune reading
Identification
of gaps
of gaps
Selection of
vertical
vertical
Personalized
protocol design
protocol design
Application
planning
planning
Integration with
treatments
treatments
Follow-up
variables
variables
Longitudinal
registry
registry
Tres Verticales Personalizadas
Cada segmento vertical responde a una necesidad clínica específica.
ONCOVIX™-IO
INMUNO-ONCOLOGÍA PERSONALIZADA
Para pacientes con cáncer que requieren una evaluación inmunobiológica complementaria, especialmente en casos de persistencia, recurrencia, metástasis, enfermedad residual, progresión o necesidad de continuidad del tratamiento.
Explorar ONCOVIX™-IO →ONCOVIX™-TOL
INMUNORREGULACIÓN TOLEROGÉNICA PERSONALIZADA
Para pacientes con enfermedades autoinmunes, inflamatorias o inmunomediadas que requieren una estrategia orientada hacia la tolerancia funcional, la regulación inmunológica y la estabilidad longitudinal.
Explorar ONCOVIX™-TOL →ONCOVIX™-REG
RECUPERACIÓN FUNCIONAL REGENERATIVA PERSONALIZADA
Para pacientes con reparación insuficiente, procesos degenerativos, secuelas, fibrosis, daño tisular, deterioro funcional o recuperación incompleta después de una cirugía, lesión o rehabilitación.
Explorar ONCOVIX™-REG →WHAT DOES AN ONCOVIX™ EVALUATION INCORPORATE?
📋 Complete Clinical History
🔬 Pathology & Imaging
🧬 Molecular Profile
⏳ Pending History
🏥 Confirmed Diagnosis
📈 Biomarkers
👤 Symptoms & Quality
📅 Follow-up Needs
💊 Treatments Used
🫀 Organ Function
🎯 Patient Objectives
🔗 Integration Possibilities
YOUR CASE IS UNIQUE.
YOUR PROTOCOL TOO.
Allow us to evaluate your information and determine which ONCOVIX™ vertical is most appropriate for your current situation.
Two Access Routes
Differentiated experience for patients/families and physicians/professionals.
Patients & Families
Learn what history to send, how the case is reviewed, what qualification means, and the admission process.
Physicians & Professionals
Review clinical and molecular fundamentals, referral criteria, mechanisms, therapeutic integration, and follow-up variables.
Institutional and Clinical Scope: The information presented is institutional, informative, and orientational in nature. Programmatic evaluation does not replace individual medical consultation or the indications of the treating team, nor does it constitute a guarantee of clinical response or a determined outcome.